Background: Nurses make a valuable contribution to pain services and have the potential to improve the safety and effectiveness of pain management. A recent addition to the role of the specialist pain nurse in the United Kingdom has been the introduction of prescribing rights, however there is a lack of literature about their role in prescribing pain medication. Objective: The aim of this study was to develop a profile of the experience, role and prescribing practice of these nurses. Design: A descriptive questionnaire survey Setting: 192 National Health Service public hospital inpatient pain services across the United Kingdom Participants: 161 qualified nurse prescribers were invited to participate, representing 98% of known nurse prescribers contributing to inpatient pain services. The survey was completed in November 2009 by 137 nurses; a response rate of 85%. Results: Compared with nurse prescribers in the United Kingdom in general, participants were highly qualified and experienced pain specialists. Fifty-six percent had qualified as a prescriber in the past 3 years and 22% reported that plans were underway for more nurses to undertake a nurse prescribing qualification. Although all participants worked in inpatient pain services, 35% also covered chronic pain (outpatient) services and 90% treated more than one pain type. A range of pain medications were prescribed, averaging 19.5 items per week. The role contained a strong educational component and contributed to informing organisational policy on pain management. Prescribing was said to improve nurses' ability to promote evidence-based practice but benefits were limited by legislation on prescribing controlled drugs. Conclusions: Findings demonstrate that pain nurses are increasingly adopting prescribing as part of their advanced nurse role. This has implications for the development needs of pain nurses in the United Kingdom and the future role development of nurses in other countries.
Introduction
Effective acute pain management is necessary not only for humanitarian reasons but also to promote recovery, prevent complications, reduce the risk of chronic pain and improve service efficiency (The Royal College of Anaesthetists, 2009) . Dedicated Acute Pain Services (APS) have been developed in the USA, Canada, New Zealand and across Europe (Nagi, 2004) . The development of APS in the United Kingdom (UK) began in the 1990's following an influential report by the Royal College of Surgeons and the College of Anaesthetists (1990) , which identified low standards of care for postoperative pain and recommended the development of multidisciplinary teams to assume responsibility for pain management, staff training, audit and research. Since then, the number of APS has steadily increased (McDonnell et al., 2003 , Nagi, 2004 , Powell et al., 2004 . While the remit of these pain services was initially to improve acute post-operative pain, in some areas this has expanded to include the management of other pain types such as cancer pain and chronic pain (Powell et al., 2004 , Counsell, 2008 .
The input of nurse specialists in the provision of APS has been advocated as good practice (The Royal College of Anaesthetists and The Pain Society, 2003) . In the UK, around 80% of APS have nurse involvement and nurses provide the largest time commitment out of all professional groups involved (Clinical Standards Advisory Group, 2000) . The role that nurses play within pain teams is continually evolving. A survey of pain nurse specialist members of the British Pain Society in the UK indicated that some nurses now manage all inpatient pain rather than just post-operative pain (Williamson-Swift, 2007) .
Nurse prescribing was introduced in the UK in order to improve patient care and make better use of the skills of healthcare professionals (Department of Health (DH) 2006). As of 2003 in England, Northern Ireland and Scotland (and 2007 in Wales) , nurses have been able to undertake a dual qualification as a Nurse Independent Prescriber (NIP) and a Nurse Supplementary Prescriber (NSP). These are two different methods of prescribing. Through NIP, nurses may independently prescribe any medicine, including a limited number of Controlled Drugs, provided that medicines are within the prescriber's area of competence (DH, 2005) . By contrast, NSP occurs in collaboration with the patient's doctor; the patient is diagnosed by the doctor and a treatment plan formulated using a document called a Clinical Management Plan (CMP). The CMP sets out the parameters within which the nurse can vary the patient's prescriptions and can include any drug, controlled or otherwise (DH, 2005) . Whereas nurses can prescribe any Controlled Drug through NSP, current legislation described by the Home Office (2007) determines which controlled drugs can be prescribed via NIP according to indication or treatment (e.g. post operative pain relief, palliative care) and route of administration. This legislation has been reviewed and a recommendation made to lift these restrictions (Home Office, 2007) .
To be accepted to train as a NIP/NSP, nurses must have the necessary pre-requisites (DH, 2006) , including a minimum of 3 years post-registration clinical experience, the final year being in the clinical field in which they will prescribe. With this dual qualification, nurses may prescribe using either method (independent or supplementary prescribing) depending on their particular work arrangements and requirements. Nurse prescribers in the UK have the most extended prescribing rights in the world (Ball, 2009 ) and over 18,000 in total have undertaken the dual qualification for NIP/NSP. There is no information available on a national basis as to how many nurse prescribers work in inpatient pain services in the UK.
The introduction of nurse prescribing potentially heralded a major change in the way in which pain services could operate. A literature review of nurse-led care in the management of acute and chronic pain (Courtenay and Carey, 2008a) identified that nurses were involved in medicines management and giving advice on prescribing, but that nurse prescribing activity was an underresearched area. Evidence suggests that pain is a therapy area for which nurses (working in a range of practice areas) frequently prescribe, both in the UK Gordon, 2009), Ireland (Drennan et al., 2009 ) and the USA (Fontana, 2008) . Of the pain nurse specialists surveyed by Williamson-Swift (2007) , 12% had undertaken a prescribing qualification. When nurses are able to prescribe for patients in pain, numerous benefits for patients, staff and services have been reported Courtenay 2008b, Kaasalainen et al., 2010) . Despite this, there is a lack of information available about the prescribing practice of nurses both in the UK and USA (Cipher et al., 2006) This is hampered by poor access to prescribing data from secondary care (hospital services) in the UK. Given the key role that nurses play in acute pain services, this is an important gap in knowledge. Improving the visibility of the nurse prescribing workforce by gaining information about nurses and their contribution to inpatient pain management is vital for the purposes of mapping change in service provision and identifying educational or support needs required to optimise best practice.
Aim
The aim of the study was to determine the number of nurse prescribers working in inpatient pain services (including APS) across the UK, and to develop a profile of these nurses in terms of their experience, role and prescribing practice.
Methods
A descriptive questionnaire survey design was chosen.
2.1
Participants To identify nurse prescribers (NIP/NSP) working in inpatient pain services, 193 healthcare provider trusts and health boards across the UK were contacted. This comprised all National Health Service (NHS) public hospital acute trusts (as of October 2009), and included 167 acute trusts in England, 14 health boards in Scotland, 7 local health boards in Wales and 5 health and social care trusts in Northern Ireland. Initial contact was made by telephone to trust switchboards to enquire about inpatient pain services, followed by contact with individual pain nurses or members of the pain team where possible within acute hospitals. In cases where a number of hospitals were included under a single trust or health board, contact was made with individual hospitals to gain this information. For Northern Ireland, the number of acute pain nurses was provided by a member of a pain network and nurses contact details were passed to the researcher with permission of these nurses.
A total of 192 inpatient pain services were identified (Table 1) , of which 126 (65.6%) were acute pain services and 66 (34.3%) were integrated pain services. No inpatient pain service was identified in 5 trusts and no answer was obtained from 2 trusts. The trusts where no inpatient pain service was identified included a women's hospital, an eye hospital and trusts in rural areas. A total of 164 qualified nurse prescribers were identified who worked in inpatient pain services.
Email addresses of 161 nurse prescribers willing to be invited to participate in the survey were obtained. We were unable to contact the three remaining nurses during the study period.
2.2
Questionnaire A 27 item questionnaire was developed specifically for this project (details of which are available on request from the corresponding author). In order to allow comparative data, questions on professional background and prescribing practice replicated, where possible, those used in previous research on nurse prescribing (Courtenay and Carey 2006 , Courtenay and Carey 2008b , Stenner and Courtenay, 2007 and questions about pain nurse role were based on research in acute pain services (Clinical Standards Advisory Group, 2000) . A pilot was conducted with 10 pain nurse prescribers prior to dissemination and minor amendments made. The questionnaire comprised mostly of fixed-choice questions with some open-ended questions set out over four sections. Section 1 covered demographic information (age, working hours, highest level of qualification), type of pain service provided and numbers of nurse prescribers working in pain teams. Section 2 asked about prescribing practice (number of years qualified, prior experience in prescribing, level of specialist training, method of prescribing used, whether they prescribed for inpatients or outpatients, and frequency of prescribing). Section 3 asked about types of medication prescribed for inpatient in pain, the envisaged impact of lifting of controlled drug legislation and if there were any restrictions on prescribing practice. Section 4 covered the pain management role (estimated time spent of different activities, who education was provided for, use of prescribing knowledge to influence protocol or local formulary and types of evidence used to inform practice). Lastly, participants were asked to rate the extent to which prescribing had enhanced ability to promote evidence based practice on a four point scale ranging from 'none' to 'very much', and asked for general comments.
The questionnaire was designed with an internet based tool for creating web surveys (Survey Monkey). An invitation letter outlining the study was sent to nurses along with an email containing a link to the online survey. The letter assured nurses that their details would remain anonymous.
Data collection took place between October and November 2009. The study gained ethical approval from the University of Surrey, Guildford, UK.
2.3
Data analysis Descriptive statistics were carried out on the data using SPSS statistical software. Non parametric tests were conducted to test for significant correlations (Spearman's Rho), and differences between variables (Chi Square and Mann-Whitney). Yates's continuity correction was applied on two-by-two tables subject to Chi Square. Free text comments were subject to content analysis and independently reviewed by a second researcher.
Results
Of the 161 nurses invited to complete an online survey, 137 responded, giving a response rate of 85%.
Nurse profile
Wide variations in job titles and pay were reported ( Table 2 ). The majority (71.5%, n=98) of job titles included the term 'nurse specialist'. There is a national pay structure for nurses in public hospitals within the UK with newly qualified nurses being paid band 5. There is then upward progression through bands 6, 7 and 8 to band 9 for the highest paid executive nurse. Pay bandings for respondents were mainly those of senior nurse roles in the UK (NHS Employers, 2009). Details of participants prescribing experience and prior training are also shown on Table 2 .
2. Pain service provision Table 3 shows the setting and type of pain services that participants provided. A third (n=48, 35%) worked across acute/chronic and/or integrated pain services and 90% (n= 123) treated more than one pain type, the remainder focusing on either acute (n=8), palliative (n=4) or chronic pain (n=2). The highest number of nurse prescribers in a pain service was 6. Fifty-three percent (n=73) had one nurse prescriber, 46% had two or more per team. Plans to increase the number of nurse prescribers were reported by 30 participants, 13 from teams with only one current prescriber.
3.3
Prescribing practice NIP was used by 89.5% (n=119), NSP by 12% (n = 16) and 10% (n= 14) were not using their prescribing qualification, mainly due to delays in obtaining registered authorisation to prescribe (n=8), or problems in finding time to arrange a CMP for NSP (n=2). The number of items nurses prescribed per week is presented in Table 4 . For NIP, the highest proportion (29%) prescribed 11-20 items for inpatients in a typical week. NSP was used less often than NIP and fewer items prescribed. The mean number of items prescribed via NIP and NSP respectively was 19.5 and 5.3. The range of medication prescribed is shown in Table 5 . Nurses working only in inpatient settings prescribed significantly more than those also working in out-patient settings (Mann-Whitney Z value -3.102, p=.002).
3.4
Impact of prescribing and restrictions Participants were asked to what extent becoming a prescriber had enhanced their ability to promote evidence based practice. Responses were 'None' (5.8%, n=8), 'A little' (17.5%, n=24), 'Quite a bit' (27.7%, n=38) and 'Very much' (40.9%, n= 56). There was a medium, positive correlation between NIP prescribing rate and the perceived impact of nurse prescribing when investigated using Spearmans Rank Order Correlation (r=.367, p<.01).
When asked what the anticipated effect would be of lifting legislative restrictions on nurse prescribing of controlled drugs, 16.9% (n=21) predicted it would make no difference to their prescribing practice, 54.8% (n=68) said it would increase the number of patients they prescribed for, 69.3% (n=86) said it would increase the range of products they prescribed and 80.6% (n=100) said it would enable them to provide better pain management. Analysis of open ended comments found that many (n=78) nurses were prevented by legislation from prescribing analgesics commonly used in their workplace. Nurses had to find a doctor to prescribe these medicines, which took time, introduced room for error, caused frustration and confusion and raised concern about equality of access to pain medication for different patients, as illustrated by the following comment:
'Changes to legislation will make significant changes to the timely delivery of analgesia in acute pain management. In addition it will reduce potential confusion that can arise between what can be prescribed in palliative care and chronic pain. Our inpatient caseload is a complex mix and current regulations increase the risk of potential error in prescribing as our nurses can prescribe from a range of opioids but not for all patients. There are inequalities and delays that inevitably result in suffering.'
Nurse role and influence
Nurses were asked to estimate the amount of time they spent on seven different activities in a typical working week; possible responses were 'no time', less than 10%, 10-30%, 30-50%, 50-70% and 70%+. Figure 1 details the percentage of nurses whose response fell into each of these categories for the seven activities. On average, nurses spent 19.5% of their time prescribing, 52.5% on hands-on pain management, 25% on staff education, 23% on patient education, 12.4% on organisational activities and 11.7% on research or audit. Comments made by respondents highlighted that these activities (such as prescribing, pain management and patient education) often overlap and occur at the same time and therefore percentages do not add up to 100%. Spearman's Rank Order Correlation revealed a significant negative correlation (r= -.302, p <.01) between job band and involvement in patient education, indicating that nurses on higher pay bands tend to spend less time on patient education. All participants provided training or education to other healthcare professionals. This included, in order of frequency: other nurses (98.4%, n=127), junior doctors or house officers (93%, n=120), students (91%, n=117), allied health professionals (82%, n=106), pharmacists (54%, n=70), nurse prescribers (38%, n=49), and General Practitioners (21%, n=27).
A large majority (81%, n = 102) had used their clinical knowledge and expertise in pain prescribing to develop local guidance or protocols on pain prescribing, 61% (n =77) had informed NHS trust drug formulary or Drugs and Therapeutic Committees (local regulatory boards for pharmacological practice) on pain prescribing issues. 16.7% (n =21) had not been involved in either of these activities. Chi-square Tests showed that nurses on band 8 were significantly more likely than those on band 7 or below to be involved in developing pain protocol (X 2 (1, n= 130) = 4.829, p = .028) and influencing formulary for pain medication (X 2 (1, n= 130) = 9.836, p=.002).
Nurses reported using a range of sources of evidence to inform their practice including (in order of frequency): the British National Formulary (BNF), World Health Organisation (WHO) analgesic ladder, local pain guidelines, drug conversion charts, journals and bulletins and the palliative care formulary.
Discussion and conclusion
This study is the first to describe the work and professional profile of nurse prescribers who treat inpatients in pain. By making the work of these nurses more visible, this study provides an important basis for future research on how these roles can be evaluated, supported and developed. It may also inform debate on the nature and shape of advanced practice within nursing.
4.1
Nurse training and experience The majority of participants were highly qualified and experienced in their field. Over 70% had more than 5 years experience in their main area of practice prior to becoming a prescriber, exceeding criteria for acceptance on the qualifying course (DH, 2006) . Age range and experience prior to prescribing were similar to those reported in previous UK nurse prescribing surveys (Courtenay et al., 2007, Courtenay and Carey, 2008b) . Compared to the most recent UK NIP/NSP survey (Courtenay and Carey 2008b) (the sample for which included general practice and community based nurses as well as nurse specialists in different areas of clinical practice), more pain nurses worked full-time, were on higher pay, had a higher level of education and had undertaken specialist training in their area of practice prior to prescribing. The proportion of nurses qualified to masters or PhD level (n =78, 56.9%) was double the 23% previously described by Courtenay and Carey (2008b) . Likewise, only 7% of pain nurses reported no specialist qualification or training in their area of practice prior to prescribing compared to 35% of nurses surveyed by Courtenay and Carey (2008b) . This level of education is more in line with the USA ( (2007) survey where high qualification levels were reported for specialist pain nurses, confirming that pain nurses are, in general, dedicated specialists who are committed to advancing their knowledge and education.
4.2
Blurred boundaries of service provision The range of services in which nurses were involved suggests a movement towards integrated pain services. This is in line with observations about the changing remit of acute pain services, which are expanding out from their original focus on post-operative pain (Powell et al., 2004 , Counsell, 2008 . Likewise, findings indicate a broadening of nurses' scope of practice to include more than one service and more than one pain category. Few nurses reported focusing on a single pain type. This adds to evidence that pain nurse specialists are increasingly working across pain categories, blurring distinctions between acute and chronic pain services (Williamson-Swift 2007) and may reflect the complexity of prescribing for inpatients whose pain can originate from multiple and migrating sources. It is known that nurse prescribers find it both confusing and restricting to work within legislation that dictates which controlled drugs can be prescribed according to the origin or pain category, particularly when treating patients who fall within the grey areas between pain categories (Stenner and Courtenay, 2007) . Lifting these restrictions, according to participants, will remove inconsistencies and improve nurses' ability to provide pain management on a fair and equal basis to all patients.
4.3
Prescribing practice Morphine products (which can be prescribed via NIP for acute pain after trauma, post-operative pain relief, palliative care and myocardial infarction) were widely prescribed. This is in keeping with the main purpose of acute pain services which is to treat patients in the post-operative period. Non-opioids (such as paracetamol, NSAIDs, anti-emetics and laxatives) and mild opioids (such as codeine and tramadol) were the most commonly prescribed medicines. These are medicines with no restrictions under the controlled drugs legislation for nurse prescribing. In contrast, strong opioids such as fentanyl, buprenorphine, and oxycodone, which NIPs may only prescribe for use in palliative care, were less commonly prescribed.
As with previous surveys, nurse independent prescribing was used more frequently than supplementary prescribing (Courtenay and Carey, 2008b) . Supplementary prescribing has been described as impractical, mainly because of difficulties implementing clinical management plans (Stenner and Courtenay, 2007) . Barriers to the use of joint prescribing agreements with a medical prescriber have also been noted in the USA (Kaplan and Brown, 2007) and Canada (Kaasalainen et al., 2010) with regards to nurse prescribing of controlled substances. The fact that many of the controlled drugs commonly used to treat pain can only be prescribed in the UK by nurses via NSP adds to the frustration created by delays in changing appropriate legislation. Our findings indicate that the range of medications prescribed by pain nurses qualified to do so will increase once this legislation is changed.
The average estimated number of items prescribed per typical week by NIP was slightly higher at 19.5 than the national average of 17.5 reported by Courtenay and Carey (2008b) . There were large variations between prescribing rates of individual nurses, the reasons for which require further research. No significant relationships or correlations were found between prescribing rate and variables such as age, educational level or pay. The lower inpatient prescribing rate for nurses who also worked in outpatient or community pain clinics is probably due to their spending less time in inpatient care than nurses working solely in inpatient settings. It is known that some hospital based nurses and medics avoid prescribing for out-patients, preferring to make recommendations to the patient's family doctor (General Practitioner) who, they believe, within the UK healthcare system, is better positioned to provide continuing care, gain full access to patient records and bear the cost of prescriptions (Stenner and Courtenay, 2007) .
4.4
Nurse role and influence A review of nurse-led care in acute and chronic pain management identified that nurses are involved in areas of pain assessment and monitoring, interdisciplinary collaboration, education and medicines management (Courtenay and Carey, 2008b) . Previous research on APS identified that acute pain nurses spend an estimated 40% of their time on hands-on pain management, 35% on staff training, 10% on patient education, and 11% on audit and research (Clinical Standards Advisory Group, 2000) . In comparison, nurses in our survey spent slightly more time on pain management (52.3% on average) and patient education (23%), and less on staff training (25%).
Other than the addition of prescribing, the patterns of activity were similar, indicating that these key elements of the pain nurse role remain the same.
Providing education on pain is considered one of the key roles of the pain nurse (WilliamsonSwift 2007) and nurse involvement in education for both patients and staff has been shown to improve patient care (Courtenay and Carey, 2008) . Almost all participants were involved in pain education and this was provided to a wide range of people. Importantly, nurses considered that becoming a prescriber had helped in the promotion of evidence-based practice, to which education contributed. Formal and informal education by pain nurses has previously been reported as important for both maintaining skills within teams and improving the consistency of evidencebased prescribing for pain, particularly amongst less experienced or junior doctors (Stenner and Courtenay, 2008a) . The opportunity for nurses to influence local prescribing policy through representation on appropriate committees has also been reported as a means to promote evidencebased practice (Stenner and Courtenay, 2008b) . In addition to providing education, participants in our study spent an average of 12% of their time on organisation-wide activities and many (83%) were influencing local pain prescribing policy. Those on higher pay bands were more likely to be involved in developing local policy and guidelines on prescribing for pain, which reflects the alignment of knowledge and skills development with pay banding, as set out in the governments Agenda for Change initiative (DH, 2004) . Nurses in the UK do not receive additional pay as a direct result of their prescribing role, however, job advertisements for nurse specialist or nurse practitioner roles increasingly request that the applicants be qualified prescribers or willing to undertake the course. It would be an interesting subject for future research to determine whether there are any implications for the career prospects of nurses who prescribe.
4.5
The future In contrast to the slow uptake of authority to prescribe controlled substances by nurse practitioners in the USA (Kaplan and Brown, 2007) , results indicate that pain management (and the prescribing of controlled drugs) is an area in which the use of nurse prescribing is increasing in the UK. Over half the participants (56%) had qualified as a prescriber in the past 3 years (i.e. since 2006) and 22% reported that plans were underway within their pain teams for more nurses to undertake the qualification.
In order for nurses to obtain permission to train as a prescriber there should be a demonstrable local need for this service (DH, 2006) . Inadequate analgesic prescribing by physicians coupled with a shortage of staff, have been cited as reasons for suboptimal pain management on surgical wards (Schafheutle et al. 2001) . It is anticipated that by prescribing for patients in pain, nurses will bring about improvements to the efficiency and quality of pain service provision. According to the views of nurse prescribers (Stenner and Courtenay 2008b) , patients will experience fewer delays in receiving pain medicine in acute settings, are likely to receive a higher standard of personalised care and more appropriate pain medication when under the care of a pain nurse prescriber. Additional benefits reported by pain nurses include improvements to service efficiency, safety, cost-effectiveness, nurse job satisfaction, inter-professional relationships and the learning environment (Stenner and Courtenay, 2008ab) . While similar benefits have been identified through interviews with nurses, doctors and patients in relation to diabetes (Courtenay et al,. 2009 (Courtenay et al,. , 2010 , dermatology (Carey et al., 2010) and mental health (Jones et al., 2007) , there has been little research on the impact of nurse prescribing on pain services. While our findings confirm that nurses believe prescribing enhances their ability to promote evidence-based practice, further evidence is needed to back these self-reported outcomes and to explore the patient perspective. As an increasing number of countries around the world are developing non-medical prescribing (Ball 2009), continued research in this area would inform and guide this expansion.
4.6
Study limitations The method used to locate the population of pain nurses was comprehensive, however, there may be nurses who were not located and invited to participate. Given the high response rate, we believe the findings accurately represent this population. While the target population was pain nurses who work in NHS inpatient services, there are other non-medical prescribers who prescribe pain medication for inpatients who were not included, such as night nurse practitioners. Further work is required to determine the profile and practice of non-medical prescribers working in NHS out-patients, pain management clinics and dedicated palliative care services.
4.7
Conclusion This study confirms that UK nurses are involved in prescribing for inpatients in pain. It emphasises the important role played by pain nurses in prescribing medicines, pain management, educating health professionals and patients, contributing to audit and research, and informing organisational policy. Given the breadth and influence of the pain nurse role, it is reassuring that these nurses were highly qualified and experienced in their field of practice. The impact that these nurses have is likely to increase when legislation restricting prescribing of controlled drugs is removed. There is therefore a need to give careful consideration to the development of such legislation in countries where NMP is advancing. Given the international expansion of NMP, it is important that its contribution is evaluated in order to inform development and enable optimum support.
